2m 2m 2m 2m 2m 2m 2m
ARS Pharma (SPRY)
NASDAQ
$4.14+$0.02 (+0.51%)
Price as of Oct 02, 2026 5:10 PM EDT- $409.7MMarket Cap
- -59.92%1-Year Change
- BiotechnologyIndustry
ARS Pharma (SPRY)
$4.14+$0.02 (+0.51%)
Earnings Score
Valuation | SPRY | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | SPRY | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -27.97% | ||
12-Month Momentum | -42.81% | ||
3-Month Risk Adjusted Momentum | -88.41% | ||
12-Month Risk Adjusted Momentum | -59.51% |
True Yield
Valuation | SPRY | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.39% | ||
Net Debt Paydown Yield | -0.01% |
Financial Health Score
Valuation | SPRY | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 2 |